Healthcare - Biotechnology - NASDAQ - US
$ 16.14
-5.34 %
$ 103 M
Market Cap
-1.86
P/E
Price Target
Average
119.95%
Revenue Forecast
Estimate
154.18%
EBIT
Estimate
--27.17%
Net Income
Estimate
11.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Assembly Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for ASMB of $35.5 , with forecasts ranging from a low of $35 to a high of $36 .
ASMB Lowest Price Target
Wall Street Target
35 USD
116.85%
ASMB Average Price Target
Wall Street Target
35.5 USD
119.95%
ASMB Highest Price Target
Wall Street Target
36 USD
123.05%
REVENUE FORECAST
Revenue Forecast Chart ASMB
EBIT FORECAST
EBIT Forecast Chart ASMB
NET INCOME FORECAST
Net Income Chart ASMB